These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5883516)

  • 1. Laboratory and clinical comparison of cephaloridine and cephalothin.
    Benner EJ; Brodie JS; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1965; 5():888-93. PubMed ID: 5883516
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro comparison of cefazolin with other cephalosporins.
    Yeivin R; Meshulam M; Sacks T
    Isr J Med Sci; 1974 Sep; 10(9):1092-5. PubMed ID: 4436031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antistaphylococcic effect of cephalothin, cephaloridine and cephazoline. I. In vitro activity].
    Martinetto P; Savoia D; Cavallo G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):374-6. PubMed ID: 5155946
    [No Abstract]   [Full Text] [Related]  

  • 4. Cephaloridine and cephalothin comparative in vitro evaluation.
    Perkins RL; Saslaw S; Hackett J
    Am J Med Sci; 1967 Mar; 253(3):293-9. PubMed ID: 4381476
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin.
    Sherris JC; Rashad AL; Lighthart GA
    Ann N Y Acad Sci; 1967 Sep; 145(2):248-67. PubMed ID: 4935172
    [No Abstract]   [Full Text] [Related]  

  • 6. Klebsiella, Enterobacter, and Serratia: biochemical differentiation and susceptibility to ampicillin and three cephalosporin derivatives.
    Zabransky RJ; Hall JW; Day FE; Needham GM
    Appl Microbiol; 1969 Aug; 18(2):198-203. PubMed ID: 4896880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the dynamics of antimicrobial agents in vivo--cephaloridine and cephalothin].
    Kitamoto O; Fukaya K; Wajima T
    J Antibiot B; 1965 Dec; 18(6):443-6. PubMed ID: 5296407
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic and clinical evaluation of cephaloridine and cephalothin in the field of surgery].
    Ishii R; Ishibiki H; Oi H; Tsunekawa Y; Nakamura Y
    J Antibiot B; 1965 Dec; 18(6):479-81. PubMed ID: 5296412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of antibacterial activity of cephapirin with cephalothin and cephaloridine to various pathogenic bacteria recently isolated from clinical materials (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1974 Apr; 27(2):157-63. PubMed ID: 4211361
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basic study on synthetic cephalosporin C--cephalothin, cephaloridine].
    Nakazawa S; Itagaki M; Yokota Y; Emoto E; Amano M
    J Antibiot B; 1965 Dec; 18(6):431-8. PubMed ID: 5329714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibacterial activity of cephalothin].
    Goto S; Kuwabara S
    J Antibiot B; 1965 Dec; 18(6):439-42. PubMed ID: 5296406
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of BL-S217, a new cephalosporin antibiotic.
    Casey F; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.
    Miraglia GJ; Renz KJ; Gadebusch HH
    Antimicrob Agents Chemother; 1973 Feb; 3(2):270-3. PubMed ID: 4790592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the testing of staphylococci for resistance to penicillinase-resistant penicillins and cephalosporins].
    Kayser FH
    Pathol Microbiol (Basel); 1967; 30(3):381-91. PubMed ID: 5182404
    [No Abstract]   [Full Text] [Related]  

  • 15. Cephaloridine, laboratory and clinical evaluation.
    Lane RA; Cox F; McHenry M; Quinn EL
    Antimicrob Agents Chemother (Bethesda); 1966; 6():88-95. PubMed ID: 5985310
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations on the mode of action of cefoxitin.
    Onishi HR; Zimmerman SB; Stapley EO
    Ann N Y Acad Sci; 1974 May; 235(0):406-25. PubMed ID: 4604846
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the clinical aspects of cephalosporins. I. Bacteriological section].
    Breitfellner G
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):174-9. PubMed ID: 4895448
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on synthetic cephalosporin C].
    Aoyama S; Moriguchi S; Takano M; Goto Y; Kawaguchi H
    J Antibiot B; 1965 Dec; 18(6):450-3. PubMed ID: 5296409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic and clinical studies on cephalosporin C antibiotics].
    Kawamori Y; Tanaka S; Mitsuse S; Furuta T; Tomimatsu S
    J Antibiot B; 1965 Dec; 18(6):447-9. PubMed ID: 5296408
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of aerobic and anaerobic Gram-negative rods to cefoxitin and related compounds.
    Yeivin R; Peretz J; Sacks T
    Isr J Med Sci; 1979 Oct; 15(10):856-8. PubMed ID: 521267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.